Market Rallies as Pfizer Secures Metsera Deal, J&J Expands Drug Application
Stock Market News·2025-10-31 20:08

Market Performance - U.S. equity markets ended positively, with the Dow Jones up 69.54 points (0.15%) to 47,591.66, the S&P 500 gaining 21.48 points (0.31%) to 6,843.82, and the Nasdaq Composite rising 165.60 points (0.70%) to 23,746.74 [2][9] Pharmaceutical Developments - Pfizer received early clearance from the U.S. Federal Trade Commission for its $4.9 billion acquisition of Metsera, aimed at enhancing its pipeline in the obesity and cardiometabolic disease market [3][9] - Johnson & Johnson submitted a supplemental Biologics License Application to the U.S. FDA for Stelara® to treat pediatric patients with moderately to severely active ulcerative colitis, potentially expanding its market [4][9] Economic Outlook and Cryptocurrency - The International Monetary Fund projects U.S. economic growth of 2.0% in 2025, indicating a stable economic outlook [5][9] - Goldman Sachs reports that cryptocurrency now constitutes 1% of the world's total investing portfolio, reflecting its growing integration into mainstream investment strategies [5][9] - Concerns arise as a federal prosecutor alleges that Bitcoin ATMs are being used for cryptocurrency scams, highlighting regulatory challenges in the crypto market [6][9] Energy Policy - The White House has removed the Atlantic from its future oil lease plans, indicating a shift in federal energy policy that may affect offshore oil and gas development along the U.S. East Coast [7][9]